Significant Innovations

Vybion is a biopharmaceutical development company specializing in human monoclonal antibody drugs for large markets with unmet needs utilizing proprietary technologies with Freedom to Operate that dramatically increases throughput and accelerates time-to-market.

Latest News

Press Release Jul 10, 2008

Denver, CO: Corgenix Medical Corporation expands effort for developing test kits for viral hemorrhagic fever detection. More

Protein Engineering Technology


ProCode™

  • Human monoclonal antibody selection
  • Affinity maturation simultaneously with selection
  • Protein solubility optimization
  • Molecule format engineering
  • Complete development and process package


Significant Innovations